SARS-CoV-2, the virus that causes COVID-19, has been linked to many different health conditions, and it can impact many ...
The COVID pandemic feels like a long time ago. Now, we have widespread immunity from vaccination and natural infection. And ...
The 2025-2026 SARS-CoV-2 vaccines provided protection against ED/UC visits and hospitalizations among immunocompetent adults.
We conducted a phase 2–3 double-blind trial to assess the efficacy and safety of nirmatrelvir–ritonavir in asymptomatic, rapid antigen test–negative adults who had been exposed to a household contact ...
World Health Organization officials first learned about a cluster of cases of pneumonia in the Hubei Province of China on Dec. 31, 2019. This represented the initial report of what soon became known ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results